E. John Wherry, PhD, Recognized With the 2023 AACR-Cancer Research Institute Lloyd J. Old Award in Cancer Immunology
PHILADELPHIA – The American Association for Cancer Research (AACR) will award E. John Wherry, PhD, with the 2023 AACR-Cancer...
Search/Filter
Loading...
Olivier Delattre, MD, PhD, Honored with 2023 AACR-St. Baldrick’s Foundation Award for Outstanding Achievement in Pediatric Cancer Research
PHILADELPHIA – The American Association for Cancer Research (AACR) will award Olivier Delattre, MD, PhD, with the 2023 AACR-St....
Patricia M. LoRusso, DO, PhD (hc), Elected as American Association for Cancer Research President-Elect for 2023-2024
Five new members elected to the Board of Directors PHILADELPHIA – The members of the American Association for Cancer...
AACR to Recognize Elizabeth M. Jaffee, MD, FAACR, with 2023 AACR-Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research
PHILADELPHIA – The American Association for Cancer Research (AACR) will honor Elizabeth M. Jaffee, MD, Fellow of the AACR...
Tak W. Mak, PhD, FAACR, Selected for 2023 Pezcoller Foundation-AACR International Award for Extraordinary Achievement in Cancer Research
PHILADELPHIA – The Pezcoller Foundation–American Association for Cancer Research (AACR) International Award for Extraordinary Achievement in Cancer Research will...
AACR Names New Editor-in-Chief of the Journal Cancer Research
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced the appointment of Christine A. Iacobuzio-Donahue, MD, PhD,...
Nobel Laureate Carolyn R. Bertozzi, PhD, to Receive 2023 AACR Award for Outstanding Achievement in Chemistry in Cancer Research
PHILADELPHIA – The American Association for Cancer Research (AACR) will honor Nobel Laureate Carolyn R. Bertozzi, PhD, with the...
AACR to Send 20 Early-career Researchers to Capitol Hill
WASHINGTON, D.C. – The American Association for Cancer Research (AACR) will host the eighth annual AACR Early-career Hill Day...
New Treatment Regimen May Decrease Mortality in Patients With Cardiotoxicity From Immune Checkpoint Inhibitors
Treatment consisted of high-dose abatacept, ruxolitinib, and proactive monitoring for respiratory muscle involvement PHILADELPHIA – Among cancer patients who...
Neoadjuvant Nivolumab Shows Long-term Benefit in Patients with Non-small Cell Lung Cancer
Study reports five-year survival outcomes PHILADELPHIA – Patients with resectable non-small cell lung cancer (NSCLC) who were treated with...